Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Bausch & Lomb and Muro to copromote Optivar

Aug. 16, 2000

Retinoid supplementation improves mouse model of childhood blindness

Aug. 11, 2000

FDA approves Rescula for treatment of glaucoma

Aug. 7, 2000

Visudyne approved in E.U. for treatment of wet AMD

Aug. 1, 2000

Tetracyclines as a valuable and relatively safe therapy for corneal ulceration

July 31, 2000

Topically applied GAG synthesis inhibitors useful for corneal haze

July 27, 2000

Nucleotides in development at Inspire for various clinical indications

July 20, 2000

Alcon claims use of AIT-082 and other neurotrophic factor enhancers in ophthalmic disorders

July 5, 2000

New market launch for Azopt

June 30, 2000

Dura to launch second Allergan product

June 20, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...